000 01064 a2200289 4500
005 20250518070308.0
264 0 _c20210621
008 202106s 0 0 eng d
022 _a1095-8541
024 7 _a10.1016/j.jtbi.2019.110067
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKumbhari, Adarsh
245 0 0 _aOptimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells.
_h[electronic resource]
260 _bJournal of theoretical biology
_c02 2020
300 _a110067 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aCancer Vaccines
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xtherapy
650 0 4 _aPeptides
650 0 4 _aT-Lymphocytes, Cytotoxic
650 0 4 _aVaccines, Subunit
700 1 _aKim, Peter S
700 1 _aLee, Peter P
773 0 _tJournal of theoretical biology
_gvol. 486
_gp. 110067
856 4 0 _uhttps://doi.org/10.1016/j.jtbi.2019.110067
_zAvailable from publisher's website
999 _c30290582
_d30290582